Horizon Therapeutics plc to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

DUBLIN--(BUSINESS WIRE)-- Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the following conference in September:

Morgan Stanley 20^th Annual Global Healthcare Conference

• Date: Tuesday, Sept. 13, 2022
• Presentation Time: 2:05 p.m. ET
• Location: New York, NY

The conference presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizontherapeutics.com. A replay of the webcast will be available for one year following the event.

About Horizon

Horizon is a global biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220825005272/en/

Investor Relations:

Tina Ventura

Senior Vice President,

Chief Investor Relations Officer

investor-relations@horizontherapeutics.com



U.S. Media:

Geoff Curtis

Executive Vice President, Corporate Affairs &

Chief Communications Officer

media@horizontherapeutics.com



Ireland Media:

Gordon MRM

Ray Gordon

ray@gordonmrm.ie

Source: Horizon Therapeutics plc